Literature DB >> 9126344

Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese.

K Higashi1, T Ishikawa, T Ito, A Yonemura, H Shige, H Nakamura.   

Abstract

Mutation frequencies in the beta 3-adrenergic receptor gene were measured in 83 CAD patients and 107 controls (all Japanese nationals) and the mutation incidence in the two groups was compared. The relationship between characteristics of lipid and glucose metabolism and presence or absence of the mutation was examined in CAD patients. The frequency of this mutant allele in CAD patients was significantly higher than that of controls. The presence of this mutation was significantly associated with higher body mass index, but not with other plasma lipid and glucose levels in CAD patients. This mutation was associated with coronary heart disease and obesity but was not with glucose and lipid metabolism disorders in Japanese nationals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126344     DOI: 10.1006/bbrc.1997.6339

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

2.  Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Michael A Pacanowski; Issam Zineh; Haihong Li; B Delia Johnson; Rhonda M Cooper-DeHoff; Vera Bittner; Dennis M McNamara; Barry L Sharaf; C Noel Bairey Merz; Carl J Pepine; Julie A Johnson
Journal:  J Transl Med       Date:  2008-03-10       Impact factor: 5.531

3.  Stratified meta-analysis by ethnicity revealed that ADRB3 Trp64Arg polymorphism was associated with coronary artery disease in Asians, but not in Caucasians.

Authors:  Yingjian Chen; Yuanjun Liao; Shengnan Sun; Fan Lin; Rang Li; Shujin Lan; Xiaolei Zhao; Jiheng Qin; Shaoqi Rao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.